References
- Freeman B A, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412–426
- Cluzel M, Damon M, Chanez P, et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 1987; 80: 195–201
- Clement A C, Chadelat K, Masliah J, Housset B, Sardet A, Grimfeld A, Tournier G. A controlled study of oxygen metabolite release by alveolar macrophages from children with interstitial lung disease. Am Rev Respir Dis 1987; 136: 1424–1428
- Strausz J, Muller-Quernheim J, Steppling H, Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1990; 141: 124–128
- Teramoto S, Fukuchi Y, Uejima Y, Chu C-Y, Orimo H. Superoxide anion formation and glutathione metabolism of blood in patients with idiopathic pulmonary fibrosis. Biochem Mol Med 1995; 55: 66–70
- Teramoto S, Chu C-Y, Ouchi Y, Fukuchi Y. Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma 1996; 33: 149–155
- Weiss T, Dorow P, Felix R. Effects of a beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with COPD. Chest 1981; 80: 881–885
- Wiemeyer JC. Influence of ambroxol on the bronchopulmonary level of antibiotics. Arzneim Forsch 1981; 31: 974–976
- Nowak D, Antczak A, Krol M, Bialasiewicz P, Pietras T. Antioxidant properties of Ambroxol. Free Radicals Biol Med 1994; 16: 517–522
- Nowak D, Pietras T, Antczak A, Krol M, Piasecka G. Ambroxol inhibits endotoxin-induced lipid peroxidation in mice. Pol J Pharmacol 1993; 45: 317–322
- Nowak D, Antczak A, Pietras T, Bialasiewicz P, Krol M. Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in mice. Eur Respir J 1994; 7: 1629–1634
- Felix K, Pairet M, Zimmermann R. The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study. Life Sci 1996; 59: 1141–1147
- Teramoto S, Fukuchi Y, Shu C Y, Orimo H. Influences of cisplatin combination chemotherapy on oxygen radical generation by blood in elderly and adult patients with lung cancer. Chemotherapy 1995; 41: 222–228
- Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Orimo H. Biochemical characteristics of lungs in senescence-accelerated mouse (SAM). Eur Respir J 1995; 8: 450–456
- Clement A, Chadelat K, Masliah J, Housset B, Sardet A, Grimfeld A, Tourier G. A controlled study of oxygen metabolite release by alveolar macrophages from children with interstitial lung disease. Am Rev Respir Dis 1987; 136: 1424–1428
- Vanhee D, Gosst P, Boitelle A, Wallaert B, Tonnel AB. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 1995; 8: 834–842
- Magna A, Mege J L, Escallier J C, et al. Balance between alveolar macrophage IL-6 and TGF-β in lung-transplant recipients. Marseille and Montreal Lung Transplantation Group. Am J Respir Crit Care Med 1996; 153: 1431–1436
- Loos U, Weiss J M, Vogel E, Musch E. N-S Arch Pharmacol 335 1987; 304, (Suppl R76) (abstract)
- Kopitar Z, Leder O. Autoradiographic studies on the distribution of 14C-labelled Bisolvon in the rat and mouse. Arzneim Forsh 1971; 21: 914–918
- Mezzetti M, Colombo L, Marini M G, Crusi V, Pierfedirici P, Mussini E. J Emerg Surg Intens Care 1990; 13: 179–185
- Calhoun W J, Stevens C A, Lambert SB. Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 1991; 117: 514–522